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The large conductance voltage- and Ca2-activated potassium (BK)
channel has been suggested to play an important role in the signal
transduction process of cochlear inner hair cells. BK channels have
been shown to be composed of the pore-forming -subunit coex-
pressed with the auxiliary 1-subunit. Analyzing the hearing
function and cochlear phenotype of BK channel - (BK/) and
1-subunit (BK1/) knockout mice, we demonstrate normal
hearing function and cochlear structure of BK1/ mice. During
the ﬁrst 4 postnatal weeks also, BK/ mice most surprisingly did
not show any obvious hearing deﬁcits. High-frequency hearing
loss developed in BK/ mice only from 8 weeks postnatally
onward and was accompanied by a lack of distortion product
otoacoustic emissions, suggesting outer hair cell (OHC) dysfunc-
tion. Hearing loss was linked to a loss of the KCNQ4 potassium
channel in membranes of OHCs in the basal and midbasal cochlear
turn, preceding hair cell degeneration and leading to a similar
phenotype as elicited by pharmacologic blockade of KCNQ4 chan-
nels. Although the actual link between BK gene deletion, loss of
KCNQ4 in OHCs, and OHC degeneration requires further investi-
gation, data already suggest human BK-coding slo1 gene mutation
asasusceptibilityfactorforprogressivedeafness,similartoKCNQ4
potassium channel mutations.
cochlea  KCNQ4
C
a2-activated potassium (BK) channels are heterooctamers
of four - and four -subunits. The pore-forming -subunit
(KCNMA1) is a member of the slo family of potassium channels
(1), originally identified in Drosophila (2). Studies of BK chan-
nels from smooth muscle have identified an auxiliary 1-subunit
(KCNMB1) whose presence in the channel complex confers an
increased voltage and calcium sensitivity toward the pore-
forming -subunit (3).
In turtle and chick, there is evidence that differential splicing
of the BK channel -subunit in conjunction with a graded
expression of the auxiliary -subunit along the tonotopic axis
provides the functional heterogeneity of BK channels that
underlies electrical tuning (for review, see ref. 4).
In inner hair cells (IHCs) of the mammalian organ of Corti,
the predominant K conductance is a voltage- and Ca2-
activated K channel termed IK,f (5, 6). BK channel mRNA (7,
8)andproteinexpression(8)wereshowninIHCs,indicatingthat
IK,f flows through BK channels. The presumed physiological
roles of BK channels are (i) a decrease of the membrane time
constant even at the resting potential and (ii) fast repolarization
of the receptor potential. Both contribute to phase-locked
receptor potentials up to high sound frequencies (6). In addition
to IHCs, BK type Ca2-activated K conductances have been
measured in OHCs (9) and in efferent fibers onto outer hair cells
(OHCs) (10). The role of BKs in either OHCs or efferents is still
controversially discussed (9).
Studying the expression of BK channel -splice variants and
-isoforms in rat cochlea using in situ hybridization and PCR
techniques revealed the strict coexpression of a minimal variant
of the -transcript with the 1-transcript (7), indicating a
functional role for both BK subunits in the mammalian cochlea.
In the present study, we used BK/ (11) and BK1/ (12)
mouse mutants to analyze the function of these channel subunits
for development of normal hearing. Besides hearing measure-
ments, the phenotype of the cochlea was studied by using
markers for efferent (13) and afferent fibers (14). The integrity
of IHCs and OHCs in adult mice was evaluated by assessing the
expression of KCNQ4 (15, 16). Expression of the postsynaptic
Ca2-dependent potassium channel SK2, which transduces spe-
cific responses of efferent neurons to OHCs (17), and the motor
protein prestin (18, 19) was examined to prove a normal OHC
phenotype.Theobservedsubcellulardistributionoftheinwardly
rectifying potassium channel subunit Kir4.1 in Deiters cells and
thestriavascularis(20)andKv3.1inthestriavascularisandspiral
ligament (21) suggested normal Deiters cell and stria vascularis
phenotypes. Although lack of BK1 subunits allowed the de-
velopment of a normal hearing function, deletion of the BK
gene resulted in progressive high-frequency hearing loss be-
tween 4 and 8 weeks, associated with a loss of active cochlear
mechanics and of KCNQ4 in OHCs of basalmidbasal cochlear
turns,suggestingapreviouslyundescribedroleoftheBKchannel
for maintenance of KCNQ4 channel expression and thereby
regular OHC function.
Materials and Methods
Animals. Care and use of the animals and the experimental
protocol were reviewed and approved by the animal welfare
commissioner and the regional board for scientific animal ex-
periments in Tu ¨bingen.
BK Channel-Deficient Mice. BK/ 129svj inbred mice were gen-
erated as described (11) and bred by mating BK/ mice at the
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Pharmacology and Toxicology, University of Tu ¨bingen. Be-
tween 4 and 18 weeks of age, BK/ were repetitively tested for
their hearing thresholds and compared with their WT litters.
Four to six cochleae of WT and BK/ of each age were
prepared for histology. BK1/ mice of 129svjC57B6 mixed
background were kindly provided by Richard Aldrich (Howard
Hughes Medical Institute, Stanford University; ref. 12) and bred
in the animal facilities of the Hearing Research Center, Uni-
versity of Tu ¨bingen. As control animals for the experiments with
the BK1/ mice, we used 12- and 30-week-old mice of a mixed
129svjC57B6 strain.
Hearing Measurements. Anesthesia of animals, measurements of
auditory brainstem responses (ABR), and distortion products of
the otoacoustic emissions (DPOAE) were performed as de-
scribed (22, 23).
Western Blot. Western Blot analysis from cochlea tissue was
performed as described (24). The specifity of the KCNQ4
antibody was verified by preadsorbing the antibody with the
antigenic peptide.
Immunocytochemistry. Cochleae were isolated, dissected, fixed,
cryosectioned, and stained as described (16, 22, 23). Anti-BK
(polyclonal anti-rabbit, Alomone Labs, Jerusalem; APC-021)
and anti-BK polyclonal antibody, recently generated (25), were
used with similar results. To generate antibodies against
KCNQ4, two rabbits were immunized (Charles River Breeding
Laboratories, Kisslegg, Germany) with synthetic peptides cor-
responding to the C-terminal domain (amino acids 682–695,
QTLSISRSVSTNMD, GenBank accession no. AF105202) of
human KCNQ4. We furthermore used the following antibodies:
affinity-purified goat polyclonal anti-KCNQ4 (polyclonal anti-
goat, sc-9385, Santa Cruz Biotechnology) and the appropriate
antigenic peptide (sc-9385 P), anti-NF200 (polyclonal anti-
sheep, The Binding Site, Heidelberg, Germany, PH187), anti-
synaptophysin (polyclonal anti-sheep, The Binding Site, PH510),
anti-cysteine string protein (CSP) (polyclonal anti-rabbit,
Chemicon; AB1576), anti-prestin (18), anti-potassium channel
SK2 (polyclonal anti-rabbit, Sigma, P0483), anti-Kir4.1 (poly-
clonal anti-rabbit, Alomone Labs; APC-035), and anti-Kv3.1b
(polyclonal anti-rabbit, Alomone Labs; APC-014). Primary an-
tibodies were detected with fluorescently labeled secondary IgG
antibodies (Cy3-conjugated antibodies, Jackson ImmunoRe-
search Laboratories, West Grove, PA; and Alexa Fluor 488-
conjugated antibodies, Molecular Probes). Sections were em-
bedded [Vectashield with 4,6-diamidino-2-phenylindole
(DAPI), Vector Laboratories, Burlingame, CA] and photo-
graphed with epifluorescence illumination (Olympus, Melville,
NY; AX70 microscope).
For hematoxylineosin staining, cochleae were thawed and
stained for 5 min (Mayers Hemalaun solution, Carl Roth,
Karlsruhe, Germany), rinsed 10 min with running water, washed
in distilled water, stained 7 min (0.1% eosin G solution in water),
washed 5 min in distilled water, and embedded (Mowiol, Cal-
biochem–Novachem).
Laser Confocal Microscopy. Cochlea of WT mice (3 weeks) were
fixed 30 min in 4% paraformaldehyde in PBS. The cochlear duct
was prepared, segmented, and stained with rabbit anti-KCNQ4,
rabbit anti-BK, and sheep anti-synaptophysin. Images were
obtained by using a confocal laser-scanning microscope (Zeiss
LSM 510), as described (16).
Terminal Deoxynucleotidyltransferase-Mediated dUTP Nick End La-
beling and Caspase-3 Double Labeling. Detection of apoptosis was
performed by using the In Situ Apoptosis Detection Kit (R&D
Systems; TA4625), a caspase-3 antibody (polyclonal anti-rabbit,
Cell Signaling Technology, Beverly, MA, #9661), and the Cell
and Tissue Staining Kit (R&D Systems, CTS005).
Results
BK Channel Expression in the Cochlea of WT and Mutant Mice. The
BK-subunit was immunohistochemically analyzed in the co-
chleae of WT, BK/, and BK1/ animals at the age of 3
weeks (Fig. 1) using double-labeling of anti-BK (red) and
anti-synaptophysin (green). With similar results, anti-BK (11,
25) and anti-BK (Alomone Labs, APC-021) were used. In both
WT (Fig. 1 A and B) and BK1/ mice (Fig. 1D), the BK
Fig.1. ImmunohistochemicallocalizationoftheBKchannel-subunitinthe
organ of Corti of WT (A and B), BK/ (C), and BK1/ (D) mice using triple
staining with anti-BK (red), anti-synaptophysin (a marker for efferent bou-
tons; green), and DAPI (a nuclear stain; blue). The experiment was replicated
with similar result (n  20). (E) Preadsorbing the BK antibody with the
antigenic peptide resulted in a complete absence of the immunoreaction.
Filled arrows point to OHC and IHC, respectively. Open arrows point to the
synaptic region of the hair cells, and arrowheads point to BK-immunoposi-
tive staining. (Bar  20 m.)
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(Fig. 1, IHC, arrowhead) and in close apposition to synaptophy-
sin-immunopositive efferents to the OHCs (Fig. 1, OHC, open
arrows). In BK/ mice, BK staining was noted neither in IHCs
nor OHCs (Fig. 1C). BK staining in OHCs but not in IHCs was
reduced in apical turns (Fig. 1A) in analogy to a well described
reduction of the number of efferent fibers toward more apical
cochlear turns (26). Anti-BK antibody specificity has been
shown recently (11), and specificity for APC-021 anti-BK was
demonstrated by complete abolishment of immunostaining by
preadsorbing the antibody with the peptide used for immuniza-
tion, shown for IHC staining (Fig. 1E, antibody specificity).
Hearing Function in BK/ and BK1/ Mice. ABR thresholds on
click auditory stimuli were not different in WT [31.0  11.1 dB
sound pressure level (SPL), mean  SD, n  10] and BK1/
mice (25.6  11.2 dB SPL, n  14; P  0.05). Frequency-
specific ABR (Fig. 2A) and distortion product measurements
(Fig. 2B) did not reveal any significant differences for WT and
BK1/ mice for mean threshold and variance at all frequen-
cies (Fig. 2A; mean: t test P  0.05, SD: F test P  0.05, n 
4–8). DPOAE thresholds as a function of f2 frequency of 16
kHz measured in WT (56.3  6.6 dB SPL, n  6), and BK1/
mutants (62.3  5.3 dB SPL, n  11) were without significant
difference (Fig. 2B; P  0.05). In line with the observed
normal hearing function, whole cell recordings from IHCs of
BK1/ mutants revealed normal BK current characteristics
(D. Oliver, personal communication).
ABR thresholds to click stimuli in WT and BK/ aged 4
weeks were similar (Fig. 3A; WT, 32.6  10.1 dB SPL, n  9;
BK/, 37.3  9.0 dB SPL, n  8; P  0.05). A significant
difference in the threshold, however, was observed when hearing
function was tested in animals at 8 weeks of age (Fig. 3B;W T ,
39.5  9.7 dB SPL, n  4; BK/, 60.9  7.5 dB SPL, n  4;
P  0.05), and in animals aged 12–17 weeks (Fig. 3C; WT, 27.2 
8.7 dB SPL, n  9; BK/, 57.1  13.9 dB SPL, n  13; P 
0.001). The final threshold loss for click stimuli was 36 dB. The
ABR thresholds for frequency-specific stimuli are shown in Fig.
3D.B K / at an age of 8–17 weeks had a significant threshold
loss of 20–30 dB in the high frequency range 8 kHz (Fig. 3D;
11.3 kHz, P  0.05; 16 kHz, P  0.001; 22.63 kHz, P  0.001; 32
kHz,P0.05).ThresholdfunctionsforWTanimalsweresimilar
for all ages tested (P  0.05) and did not show an age-related
threshold loss or increase in variation (average SD, 14.5, 11.8,
13.9, and 14.6 for ages 4, 8, 12–14, and 17 weeks, respectively; F
test P  0.05).
DPOAE thresholds were measured as a function of f2 fre-
quency of 16 kHz. Fig. 3E gives the numbers of ears where
DPOAEs could be reported. In 10 of 20 WT and 4 of 4 BK/
ears, DPOAEs were found. With our methods for measuring
DPOAEs, significantly, DPOAEs could be found in none of the
BK/ mice tested (n  17), independent of age (2 test,
P  0.05).
Structural Evaluation of the Organ of Corti of BK Channel-Deficient
Mice.TheorganofCortiofWTmice(Fig.4A)andBK1/mice
(Fig. 4B) did not show any difference in animals aged 14 weeks
when stained with hematoxylineosin. In contrast, in BK/
animals of the same age, when significant hearing loss was
alreadynoted,aseveredegenerationofOHCscouldbeobserved
in the basal and midbasal cochlear turns (Fig. 4C, OHC),
whereas we could not detect any noticeable changes in the IHC
structure at that time (Fig. 4C, IHC).
The loss of OHCs at this age was accompanied by a detectable
fragmentation of DNA and appearance of caspase-3 in Deiters
cells (Fig. 4 D and E, open arrows). No signs of apoptosis were
noted in the same sections in the stria vascularis and spiral
ligament (data not shown).
Phenotype of the Cochlea at the Onset of Hearing Loss. Using Kir4.1
(20) and Kv3.1 (21) as markers for a presumptive normal
phenotype of stria vascularis or spiral ligament fibrocytes, we
were unable to detect alterations of the expression patterns in
BK/ mice in comparison to WT mice within the time period
analyzed (data not shown).
Using CSP, which labels IHCs and efferent synapses (27), we
could not detect any significant difference in IHC CSP expres-
sion in 4-, 8-, or 14-week-old WT and BK/ mice (Fig. 5, IHC,
Fig. 2. ABR and DPOAE thresholds for WT and BK1/ mice. (A) ABR
thresholds as a function of frequency for WT (circles) and BK1/ mice of 12
weeks (triangles) and 20–30 weeks (squares) of age. Standard deviations (not
showningraphforclarityreasons):WT,10.8(2.0–24.2);BK1/12weeks,9.6
(2.3–21.7); 20–30 weeks, 8.1 (2.5–16.8). (B) DPOAE thresholds (dB SPL f1) at
f2  16 kHz for individual WT (circles) and BK1/ (squares) mice. Horizontal
lines show the mean values.
Fig. 3. ABR thresholds of WT (circles) and BK/ mice (triangles) (A–D) and
number of ears with DPOAEs found (E). (A–C) ABR thresholds (dB SPLrms)t o
click stimuli, given for individual mice (open symbols) and as mean (ﬁlled
symbols)  standard deviation as a function of age (A, 4 weeks; B, 8 weeks; C,
12–17 weeks). (D) ABR thresholds as a function of stimulus frequency for WT
(circles) and BK/ (triangles) mice of 8–17 weeks of age. (E) Number of ears
with DPOAEs found. DPOAE function below 10 dB SPL could not be detected
due to limitations of the method.
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isolated IHCs of hearing-impaired BK/ mice up to 14 weeks
using RT-PCR was normal (data not shown). No differences in
CSP expression were noted in efferent synapses below OHCs in
normal hearing BK/ mice at 4 weeks (Fig. 5, OHC), whereas
CSP-immunopositive efferent synapses were absent in hearing-
impaired BK/ mice aged 14 weeks (Fig. 5, OHC). These
results suggest a progressive degeneration of typical OHC phe-
notype causing the hearing deficit.
Next, we studied the influence of BK deletion on the
maintenance of the final phenotype of OHCs upon analyzing the
expression of OHC ion channels such as KCNQ4, prestin, and
SK2, or Kir4.1 channels expressed in the neighboring Deiters
cells (20). Anti-KCNQ4 antibodies stained proteins at the OHC
base (Fig. 6A), similar to the pattern described (15), and
crossreactedwithacorrespondingpolypeptideof77kDainthe
absence but not presence of the antigenic peptide (Fig. 6D).
Surprisingly, a loss of KCNQ4 in OHC membranes was noted
before other overt signs of degeneration became evident. Three
of six analyzed cochleae of 8-week-old BK/ mice exhibited
this early stage of degeneration shown in Fig. 6. At this time,
BK/ animals exhibited the exclusive loss of KCNQ4 proteins
in OHCs of the basal and midbasal cochlear turns (Fig. 6A,
midbasal, KCNQ4, open arrow) but not of the medial and apical
cochlearturns(Fig.6A,apical,openarrow).Inthesamecochlea,
nearly all other proteins analyzed appeared to be normal,
including prestin expression (Fig. 6A), Kir4.1 protein (Fig. 6B),
synaptophysin-immunopositive efferent synaptic bodies (Fig.
6C, open arrow), and the postsynaptic SK2 channel protein (Fig.
6C, closed arrow).
Alteration of the Phenotype of the Cochlea During Hearing Loss. The
degeneration process in OHCs of BK/ mice subsequent to
Fig. 4. Assessment of degenerative (A–C) and apoptotic (D and E) processes
intheorganofCortiofWT,BK1/,andBK/miceattheageof14weeks.
(A–C) Hematoxylineosin staining reveals morphological integrity of the mid-
basal cochlear turn in WT (A) and BK1/ (B) mice compared with severe
degenerationofOHCsinBK/animals(C).(DandE)DoublelabelingofDNA
fragmentation (terminal deoxynucleotidyltransferase-mediated dUTP nick
end labeling staining) and caspase-3 immunoreactivity as a marker for apo-
ptosis.FilledarrowsdepictthreerowsofOHCsandtheIHC;openarrowsdepict
Deiters cells. (Bar  20 m.)
Fig. 5. Immunohistochemical assessment of the phenotype of the organ of
Corti by using the synaptic vesicle marker anti-CSP (red) and the nuclear stain
DAPI (blue) in midbasal cochlear turns in WT and BK/, 4 and 14 weeks. CSP
staining is noted in IHCs and efferent synapses. Note the reduced CSP immu-
noreactivityattheOHCbutnotIHClevelinBK/animalsat14weeks.(Bar
20 m.)
Fig. 6. Absence of KCNQ4 immunoreactivity in OHCs as a ﬁrst indicator of
loss of OHC phenotype. Cochlear sections of WT and BK/ (8 weeks) of
different turns were triple-stained for KCNQ4 (green), prestin (red), and DAPI
(blue) (A); Kir4.1 (red), synaptophysin (green), and DAPI (blue) (B); and SK2
(red), synaptophysin (green), and DAPI (blue) (C). Note the decline of KCNQ4
in the midbasal but not apical cochlear turn in BK/ mice, whereas prestin,
synaptophysin, SK2, and Kir4.1 expression was still normal. (D) KCNQ4 anti-
body speciﬁcity was conﬁrmed by detection of a band at the predicted
molecular mass of 77 kDa in Western blot in membranes of cochlear tissue
(lane 1) and the abolition of the 77-kDa Western signal by preadsorbing the
antibody with the antigenic peptide (lane 2). (Bar in A and B  50 m; in C 
20 m.)
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over age, always occurred in the same sequence: (i) reduction of
the size of efferent synaptic bodies, with a parallel reduction of
the area of OHC membrane occupied by SK2 channels; (ii)
disappearance of Kir4.1 from Deiters cells; (iii) complete loss of
synaptophysin- or CSP-immunopositive efferents contacting the
OHCs in basal and midbasal cochlear turns; and (iv) shrinkage
of the membranes of OHCs with reduction of prestin protein.
Fig. 7 shows OHCs in a midbasal cochlear turn in WT and
BK/ at 14 weeks at a stage where simple light microscopy
of OHCs would hardly reveal an alteration, and the staining of
OHCs nuclei would suggest the existence of apparently normal
OHCs (note the DAPI-stained OHC nuclei in Fig. 7 A–C). At
this stage, a loss of KCNQ4 from OHC membranes was
associated with a reduction of prestin protein in lateral
membranes (Fig. 7A, KCNQ4, open arrows), the absence of
synaptophysin-immunopositive boutons opposite OHCs (Fig.
7B, open arrows), and a complete vanishing of Kir4.1 from the
apical Deiters cell membrane (Fig. 7C, open arrows). Normal
KCNQ4 expression pattern was noted in the hair cells of the
sacculus in the same cochlea (Fig. 7D).
Spatial Localization of BK Channels at OHCs. Laser confocal mi-
croscopy at the base of OHCs reveals a cup-form shape of
KCNQ4 immunostaining shown from three different points of
view(Fig.8A,red)withafreespot,occupiedbysynaptophysin-
immunopositive efferent boutons (Fig. 8A, green). Confocal
image stacks of the BK and synaptophysin-immunoreactive
area at the OHC level in turn revealed the total spatial
separation of both BK and synaptophysin staining patterns
(Fig. 8B), demonstrating that the BK proteins are localized at
the postsynaptic (OHC) side relative to the synaptophysin-
immunopositive presynapse.
Discussion
Here, we show that mice lacking the BK channel pore-forming
-subunit apparently do not exhibit a congenital hearing loss, as
would have been expected from the BK expression profile in
IHC, but rather develop mild progressive high-frequency hear-
ing loss, based on an alteration of the OHC phenotype. In
contrast, mice lacking the auxiliary BK channel 1 gene do not
exhibit any hearing deficits and have a normal cochlear pheno-
type. The data highlight unexpected previously undescribed
functions of the BK channel complex for the inner ear.
BK1/ Mice Have Normal Hearing and a Normal Cochlear Pheno-
type. In lower vertebrates, electrical tuning along the tonotopic
axis is provided by differential BK channel expression (for
review, see ref. 4). In the mammalian cochlea, however, tuning
is based on the mechanical properties of the basilar membrane.
Therefore, a role of the 1 subunit as a differential Ca2 sensor
is not to be expected in mammals. The data in the present study
clearly indicate that BK1 plays no critical role for the normal
basic hearing function. It cannot be excluded, however, that
more intricate properties in the IHC transduction process are
affected by the deletion of BK1 that could not be resolved with
the techniques used.
BK Deletion Leads to Hearing Loss Despite Normal Phenotypes of
Stria Vascularis and Spiral Ligament.BKchannelswereshowntobe
present in the stria vascularis by immunocytochemistry (8) and
electrophysiology (28) as well as in fibrocytes of the spiral
ligament by electrophysiology (29). Although we cannot exclude
effects on the endocochlear potential in BK/ mice older than
those studied here, we were unable to detect any phenotypical
change in the stria vascularis in BK/ mice, in line with the
described profile of hearing loss.
BK Deletion Leads to Hearing Loss Despite Inconspicuous IHC Phe-
notype. Kros et al. (6) argued that the BK current in IHCs is
essential for a graded receptor potential and phase locking to
frequencies in the kHz range. Whether phase locking was
Fig.7. LossofOHCphenotypeat14weeksofage.Midbasalcochlearsections
of WT and BK/ animals were triple-stained for prestin (red), KCNQ4
(green), and DAPI (blue) (A); double-stained for synaptophysin (green) and
DAPI (blue) (B); and triple-stained for Kir4.1 (red), synaptophysin (green), and
DAPI (blue) (C). (D) The vestibular organ (sacculus) was double-stained for
KCNQ4 (red) and DAPI (blue). Note the loss of OHC phenotype in BK/
mutants. (Bar  20 m.)
Fig. 8. Subcellular distribution of BK and KCNQ4 channels in OHCs. (A)3 D
reconstruction of confocal image stacks of an OHC (whole-mount prepara-
tion,midbasalturn)stainedforKCNQ4(red)andsynaptophysin(green).(B)3D
reconstructionofconfocalimagestacksofanOHC-efferentsynapse(midbasal
turn) stained for BK (red) and synaptopysin (green). Note that BK is localized
atthepostsynapticsideofthesynaptopysin-immunopositiveefferentpresyn-
apse. (Bar in A  10 m; in B  2.5 m.)
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techniques used in this study. However, normal hearing function
up to age 4 weeks indicates that graded receptor potentials are
possible without BK. Recently, evidence was presented for the
presence of KCNQ4 channels in IHCs (16, 30). Although
KCNQ4 provides a small maximum conductance, it is activated
at the resting potential to 75%, which adds substantially to the
total K conductance around the resting potential, thereby
contributing to a graded receptor potential. Expression of
presynaptic elements of a normal IHC phenotype, such as CSP,
a regulator of SNARE protein interactions (31), and Cav1.3 in
BK/ at least within the first 4 months underlines a probable
normal IHC phenotype in the absence of BK. Future studies
using conditional BK gene deletion restricted to IHCs may
exclude presumptive gene redundancy after embryonic gene
deletion.
BK Gene Deletion Leads to Hearing Loss Associated with OHC
Degeneration. BK/ mice develop high-frequency hearing loss
and loss of DPOAEs after 2 months of age, concomitant with
the first detectable sign of an altered cochlear phenotype, the
disappearance of KCNQ4 from the OHC membranes in high-
frequency regions of the cochlea.
ThephenotypeofKCNQ4/micehasnotyetbeendescribed.
However, a phenotype of mice after chronic block of KCNQ4 by
linopirdine has been reported (32). The authors found a pro-
gressive loss of basal and midbasal but not apical OHCs, no
influence on IHCs, reduced DPOAE amplitudes, and no effect
on the endocochlear potential, indicating a normal stria vascu-
laris, a nearly identical phenotype, as outlined here for the
BK/ mice. The striking similarity between the results of both
studies leads to the conclusion that loss of KCNQ4 function in
OHCs may lead to OHC degeneration. A possible explanation
is that K ions entering through the transduction channels lack
a major exit route out of the OHCs, thus leading to chronic
depolarization. The depolarization may cause induction of apo-
ptosis via sustained Ca2 influx through voltage-activated Ca2
channelsCav1.3(33).Thedepolarizationalsoreducesthedriving
force that may explain the observed reduction in DPOAEs. Most
interestingly in this context, KCNQ4 mutations (34) could be
linked to hereditary deafness DFNA2 (35, 36), a hereditary
disease that also results in progressive hearing loss for high-
frequency sounds.
The distinct localization of BK channels opposite the efferent
boutons (Fig. 8), occupying the same region as the SK2 channel
(17), suggests a vital role of the BK current in the efferent
inhibitory control. Whatever the function of BK on OHCs level,
the similarity of basal to apical declining gradients of BK
expression (present study) and the gradient of efferents (26) and
presumptively afferent type II (22) indicates that BK channels
play a role in maintaining those OHCs that receive efferent
inhibitory feedback from the brain.
It will be a challenging topic of future research to uncover the
series of events leading from BK gene disruption to loss of
KCNQ4expression.Butthedatapresentedherealreadystrongly
suggest that human slo1 must be considered an important
susceptibility factor for progressive deafness analogous to
KCNQ4 channel mutations (33).
This paper is dedicated to Alfons Ru ¨sch. We thank Drs. Robert Brenner
and Richard W. Aldrich (Department of Molecular and Cellular Phys-
iology and Howard Hughes Medical Institute, Stanford University,
Stanford, CA) for the generous supply of BK1 knockout mice. This
work was supported by Deutsche Forschungsgemeinschaft Grants DFG
Ru419, DFG Kni3163-2, DFG Ru5714-1, SFB 430-B3, and by Fortune
816-0-0.
1. Knaus, H. G., Garcia-Calvo, M., Kaczorowski, G. J. & Garcia, M. L. (1994)
J. Biol. Chem. 269, 3921–3924.
2. Elkins, T., Ganetzky, B. & Wu, C. F. (1986) Proc. Natl. Acad. Sci. USA 83,
8415–8419.
3. McManus, O. B., Helms, L. M., Pallanck, L., Ganetzky, B., Swanson, R. &
Leonard, R. J. (1995) Neuron 14, 645–650.
4. Fettiplace, R. & Fuchs, P. A. (1999) Annu. Rev. Physiol. 61, 809–834.
5. Dulon, D., Sugasawa, M., Blanchet, C. & Erostegui, C. (1995) Pflu ¨gers Arch.
430, 365–373.
6. Kros, C. J., Ruppersberg, J. P. & Rusch, A. (1998) Nature 394, 281–284.
7. Langer, P., Grunder, S. & Rusch, A. (2003) J. Comp. Neurol. 455, 198–209.
8. Skinner, L. J., Enee, V., Beurg, M., Jung, H. H., Ryan, A. F., Hafidi, A., Aran,
J. M. & Dulon, D. (2003) J. Neurophysiol. 90, 320–332.
9. Mammano, F. & Ashmore, J. F. (1996) J. Physiol. 496, 639–646.
10. Wangemann, P. & Takeuchi, S. (1993) Hear. Res. 66, 123–129.
11. Sausbier, M., Hu, H., Arntz, C., Feil, S., Kamm, S., Adelsberger, H., Sausbier,
U., Sailer, C. A., Feil, R., Hofmann, F., et al. (2004) Proc. Natl. Acad. Sci. USA
101, 9474–9478.
12. Brenner,R.,Jegla,T.J.,Wickenden,A.,Liu,Y.&Aldrich,R.W.(2000)J.Biol.
Chem. 275, 6453–6461.
13. Knipper, M., Zimmermann, U., Rohbock, K., Kopschall, I. & Zenner, H. P.
(1995) Brain Res. Dev. Brain Res. 89, 73–86.
14. Fermin, C. D., Martin, D. S. & Hara, H. (1997) Cell Vis. 4, 280–297.
15. Kharkovets, T., Hardelin, J. P., Safieddine, S., Schweizer, M., El-Amraoui,
A., Petit, C. & Jentsch, T. J. (2000) Proc. Natl. Acad. Sci. USA 97, 4333–
4338.
16. Oliver, D., Knipper, M., Derst, C. & Fakler, B. (2003) J. Neurosci. 23,
2141–2149.
17. Oliver,D.,Klocker,N.,Schuck,J.,Baukrowitz,T.,Ruppersberg,J.P.&Fakler,
B. (2000) Neuron 26, 595–601.
18. Weber, T., Zimmermann, U., Winter, H., Mack, A., Kopschall, I., Rohbock,
K., Zenner, H. P. & Knipper, M. (2002) Proc. Natl. Acad. Sci. USA 99,
2901–2906.
19. Zheng, J., Shen, W., He, D. Z., Long, K. B., Madison, L. D. & Dallos, P. (2000)
Nature 405, 149–155.
20. Hibino, H., Horio, Y., Inanobe, A., Doi, K., Ito, M., Yamada, M., Gotow, T.,
Uchiyama, Y., Kawamura, M., Kubo, T. & Kurachi, Y. (1997) J. Neurosci. 17,
4711–4721.
21. So, E., Kikuchi, T., Ishimaru, K., Miyabe, Y. & Kobayashi, T. (2001) Neuro-
Report 12, 2761–2765.
22. Schimmang, T., Tan, J., Muller, M., Zimmermann, U., Rohbock, K., Kopschall,
I., Limberger, A., Minichiello, L. & Knipper, M. (2003) Development (Cam-
bridge, U.K.) 130, 4741–4750.
23. Knipper, M., Zinn, C., Maier, H., Praetorius, M., Rohbock, K., Kopschall, I. &
Zimmermann, U. (2000) J. Neurophysiol. 83, 3101–3112.
24. Knipper, M., Richardson, G., Mack, A., Muller, M., Goodyear, R., Limberger,
A.,Rohbock,K.,Kopschall,I.,Zenner,H.P.&Zimmermann,U.(2001)J.Biol.
Chem. 276, 39046–39052.
25. Steffens,F.,Zhou,X.B.,Sausbier,U.,Sailer,C.,Motejlek,K.,Ruth,P.,Olcese,
J., Korth, M. & Wieland, T. (2003) Mol. Endocrinol. 17, 2103–2115.
26. Liberman, M. C. & Brown, M. C. (1986) Hear. Res. 24, 17–36.
27. Eybalin, M., Renard, N., Aure, F. & Safieddine, S. (2002) Eur. J. Neurosci. 15,
1409–1420.
28. Takeuchi, S., Marcus, D. C. & Wangemann, P. (1992) Hear. Res. 61, 86–96.
29. Liang, F., Niedzielski, A., Schulte, B. A., Spicer, S. S., Hazen-Martin, D. J. &
Shen, Z. (2003) Pflu ¨gers Arch. 445, 683–692.
30. Marcotti, W., Johnson, S. L., Holley, M. C. & Kros, C. J. (2003) J. Physiol. 548,
383–400.
31. Chamberlain, L. H. & Burgoyne, R. D. (2000) J. Neurochem. 74, 1781–1789.
32. Nouvian, R., Ruel, J., Wang, J., Guitton, M. J., Pujol, R. & Puel, J. L. (2003)
Eur. J. Neurosci. 17, 2553–2562.
33. Michna, M., Knirsch, M., Hoda, J. C., Muenkner, S., Langer, P., Platzer, J.,
Striessnig, J. & Engel, J. (2003) J. Physiol. 553, 747–758.
34. Kubisch, C., Schroeder, B. C., Friedrich, T., Lutjohann, B., El-Amraoui, A.,
Marlin, S., Petit, C. & Jentsch, T. J. (1999) Cell 96, 437–446.
35. Coucke, P. J., Van Hauwe, P., Kelley, P. M., Kunst, H., Schatteman, I., Van
Velzen, D., Meyers, J., Ensink, R. J., Verstreken, M., Declau, F., et al. (1999)
Hum. Mol. Genet. 8, 1321–1328.
36. Van Hauwe, P., Coucke, P. J., Ensink, R. J., Huygen, P., Cremers, C. W. & Van
Camp, G. (2000) Am. J. Med. Genet. 93, 184–187.
Ru ¨ttiger et al. PNAS  August 31, 2004  vol. 101  no. 35  12927
C
E
L
L
B
I
O
L
O
G
Y